2 Mins
20 Jul 2023
UBA1 Non-M41 Variants Are More Aggressive than UBA1 M41 Variants in Their Haematological Manifestations
The ongoing large-scale screen of non-M41 variants in patients suspected of HMs continues to detect both recurrent and novel non-M41 variants. The patients harbouring non-M41 variants are rare but may be more malignant.
6 Mins
20 Jul 2023
Putting Guidelines into Practice: Supporting Young People with Hereditary Angioedema to Live Attack-Free
The availability of specific licensed medicines to treat acute HAE attacks and prophylactic options to prevent future episodes is changing the way people with HAE are treated, and is giving them hope for a future free from debilitating HAE attacks.
4 Mins
20 Jul 2023
Transplantation Versus Gene Therapy for Sickle Cell Disease
A captivating session, presented at EHA Congress 2023, on sickle cell disease explored the role of allogeneic stem cell transplantation in this condition, as well as gene therapy and gene editing in treating patients with SCD.
1 Mins
20 Jul 2023
Introducing the Concept of Patient Blood Management and Haemovigilance in Government Sector Hospitals of Sindh, Pakistan
Patient blood management encompasses all aspects of the transfusion decision-making process, beginning with the initial patient evaluation and continuing through clinical management.
4 Mins
20 Jul 2023
EAACI Guidelines on Diagnosis of Food Allergy: What Is New?
An engaging session presenting the newly-revised European Academy of Allergy and Clinical Immunology guidelines on the diagnosis of food allergy, centred around the accuracy of diagnostic tests and recommendations for practice.
